554 related articles for article (PubMed ID: 34829907)
1. Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson's Disease.
Ko CJ; Gao SL; Lin TK; Chu PY; Lin HY
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829907
[TBL] [Abstract][Full Text] [Related]
2. Iron Metabolism in Ferroptosis.
Chen X; Yu C; Kang R; Tang D
Front Cell Dev Biol; 2020; 8():590226. PubMed ID: 33117818
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
[TBL] [Abstract][Full Text] [Related]
6. ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons.
Bouchaoui H; Mahoney-Sanchez L; Garçon G; Berdeaux O; Alleman LY; Devos D; Duce JA; Devedjian JC
Free Radic Biol Med; 2023 Feb; 195():145-157. PubMed ID: 36581060
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis: A potential therapeutic target for neurodegenerative diseases.
Vitalakumar D; Sharma A; Flora SJS
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22830. PubMed ID: 34047408
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis in Parkinson's disease: glia-neuron crosstalk.
Wang ZL; Yuan L; Li W; Li JY
Trends Mol Med; 2022 Apr; 28(4):258-269. PubMed ID: 35260343
[TBL] [Abstract][Full Text] [Related]
9. Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis.
Jiang X; Wu K; Ye XY; Xie T; Zhang P; Blass BE; Bai R
Med Res Rev; 2023 Jul; 43(4):872-896. PubMed ID: 36924451
[TBL] [Abstract][Full Text] [Related]
10. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
Carvalho FV; Landis HE; Getachew B; Silva VDA; Ribeiro PR; Aschner M; Tizabi Y
Adv Neurotoxicol; 2024; 11():105-132. PubMed ID: 38770370
[TBL] [Abstract][Full Text] [Related]
11. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
[TBL] [Abstract][Full Text] [Related]
12. Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment.
Mohan S; Alhazmi HA; Hassani R; Khuwaja G; Maheshkumar VP; Aldahish A; Chidambaram K
Heliyon; 2024 Feb; 10(3):e24786. PubMed ID: 38314277
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Insights on Ferroptosis in Parkinson's disease.
Thapa K; Khan H; Kanojia N; Singh TG; Kaur A; Kaur G
Eur J Pharmacol; 2022 Sep; 930():175133. PubMed ID: 35792170
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis as a New Mechanism in Parkinson's Disease Therapy Using Traditional Chinese Medicine.
Wu L; Liu M; Liang J; Li N; Yang D; Cai J; Zhang Y; He Y; Chen Z; Ma T
Front Pharmacol; 2021; 12():659584. PubMed ID: 34163356
[TBL] [Abstract][Full Text] [Related]
15. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
Maru D; Hothi A; Bagariya C; Kumar A
Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
[TBL] [Abstract][Full Text] [Related]
16. Lipid Metabolism in Ferroptosis.
Lin Z; Liu J; Kang R; Yang M; Tang D
Adv Biol (Weinh); 2021 Aug; 5(8):e2100396. PubMed ID: 34015188
[TBL] [Abstract][Full Text] [Related]
17. New Target for Prevention and Treatment of Neuroinflammation: Microglia Iron Accumulation and Ferroptosis.
Liu S; Gao X; Zhou S
ASN Neuro; 2022; 14():17590914221133236. PubMed ID: 36285433
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.
Zhou J; Jin Y; Lei Y; Liu T; Wan Z; Meng H; Wang H
Neurodegener Dis; 2020; 20(1):20-34. PubMed ID: 32814328
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders.
David S; Jhelum P; Ryan F; Jeong SY; Kroner A
Antioxid Redox Signal; 2022 Jul; 37(1-3):150-170. PubMed ID: 34569265
[No Abstract] [Full Text] [Related]
20. miR‑335 promotes ferroptosis by targeting ferritin heavy chain 1 in
Li X; Si W; Li Z; Tian Y; Liu X; Ye S; Huang Z; Ji Y; Zhao C; Hao X; Chen D; Zhu M
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
